Search
moon
sun

T229. Hyperthyroidism and thyroid storm

A. Introduction and epidemiology

โ€ข
Thyroid hormone : Thyroxine (T4), Triiodothyronine (T3) : ํ˜ˆ์•ก์œผ๋กœ ์œ ๋ฆฌ๋  ๋•Œ T4 : T3 = 10 : 1 ์˜ ๋น„์œจ๋กœ release ๋จ. : ๋ง์ดˆ์—์„œ T4 (๋ฐ˜๊ฐ๊ธฐ 7์ผ)๊ฐ€ ํ™œ์„ฑ T3 (๋ฐ˜๊ฐ๊ธฐ 1์ผ)๋กœ ๋ฐ”๋€Œ๊ณ  ํ™œ์„ฑ T3๋Š” T4๋ณด๋‹ค 3~4๋ฐฐ ๋” potent
โ€ข
Hyperthyroidism : ์ฒด๋‚ด ๊ฐ‘์ƒ์„  ํ˜ธ๋ฅด๋ชฌ์˜ ๊ณผ์ž‰์œผ๋กœ ์ผ์–ด๋‚˜๋Š” ์ง•ํ›„ ๋ฐ ์ฆ์ƒ์˜ ์‹ ๋“œ๋กฌ : โ€˜thyrotoxicosisโ€™์™€ ๊ฐ™์€ ์˜๋ฏธ๋กœ ์‚ฌ์šฉ๋˜๋Š” ์šฉ์–ด์ž„.
โ€ข
Thyroid storm : Hyperthyroidism์˜ extreme manifestation ์ƒํƒœ. : Acute, severe, life-threatening hypermetabolic state : ๊ฐ‘์ƒ์„  ํ˜ธ๋ฅด๋ชฌ์˜ ๊ณผ๋‹ค ๋ถ„๋น„์— ์˜ํ•œ adrenergic hyperactivity ๋˜๋Š” ์ฆ๊ฐ€๋œ ๋ง์ดˆ ๋ฐ˜์‘์— ์˜ํ•ด ๋ฐœ์ƒ : m/c : Gravesโ€™ disease (85%, TSH ์ˆ˜์šฉ์ฒด Ab ๋•Œ๋ฌธ์— ๊ณผ๋„ํ•œ ํ•ฉ์„ฑ, ๋ถ„๋น„๊ฐ€ ์ž๊ทน๋จ)

B. Hyperthyroidism

โ€ข
์ผ์ฐจ์„ฑ : ๊ฐ‘์ƒ์„  ์ž์ฒด์˜ ๋ฌธ์ œ๋‚˜, ์™ธ๋ถ€์š”์ธ (์•ฝ๋ฌผ ๋“ฑ)์œผ๋กœ ์ธํ•ด ๊ฐ‘์ƒ์„  ํ˜ธ๋ฅด๋ชฌ ๊ณผ๋ถ„๋น„ (Table 229-2)
โ€ข
์ด์ฐจ์„ฑ : TSH (pituitary gland), TRH (hypothalamus) ๋ฌธ์ œ (Table 229-1)

B1. Clinical features

โ€ข
๋‹จ์ˆœํžˆ ์ „์‹  ๊ธฐ๋ ฅ์ €ํ•˜๋‚˜ ํ”ผ๋กœ๊ฐ๋งŒ ํ˜ธ์†Œํ•  ์ˆ˜๋„ ์žˆ๋‹ค.
โ€ข
๋”์œ„์ž˜ํƒ. ๋ฐœํ•œ, ๋ฐœ์—ด, ์ฒด์ค‘์ด ์ž˜ ์•ˆ ๋Š  (์ž˜ ๋จน๋Š”๋ฐ๋„), ์ดˆ์กฐ, ๊ฐ์ •์  lability, ์‹ฌ๊ณ„ํ•ญ์ง„, ์„ค์‚ฌ, ํƒˆ๋ชจ (Table 229-3) ๋“ฑ์˜ ์ฆ์ƒ ๋ฐœ์ƒ
โ€ข
hyperthyrodism์˜ ๋ณ‘๋ ฅ ์ด ์žˆ์œผ๋ฉด ์น˜๋ฃŒ์—ฌ๋ถ€๋‚˜ ์•ฝ๋ฌผ์˜ ์ˆœ์‘๋„๋ฅผ ํ™•์ธํ•ด์•ผ ํ•จ
โ€ข
Exophthalmos๋Š” ์งˆ๋ณ‘์˜ ์ง„ํ–‰์ •๋„์™€ ๊ฐ™์ด ๋‚˜ํƒ€๋‚˜์ง€๋Š” ์•Š์Œ
โ€ข
๋ชจ๋“  ๊ฐ‘์ƒ์ƒ˜๊ธฐ๋Šฅํ•ญ์ง„์—์„œ goiter๊ฐ€ ๋‚˜ํƒ€๋‚˜์ง€๋Š” ์•Š๋Š”๋‹ค. (goiter ์žˆ๋‹ค๊ณ  ๋ชจ๋‘ ํ•ญ์ง„์ฆ์ธ ๊ฒƒ๋„ ์•„๋‹ˆ๋‹ค)
โ€ข
๊ฐ‘์ƒ์ƒ˜ ์••ํ†ต์€ ์•„๊ธ‰์„ฑ ๊ฐ์ƒ์„ ์—ผ๊ณผ ๊ฐ™์€ ์—ผ์ฆ์ด ์žˆ๋Š” ๊ฒฝ์šฐ๋Š” ์žˆ์„ ์ˆ˜ ์žˆ๋‹ค

B2. Laboratory testing

(1) TSH

โ€ข
์ผ์ฐจ์„ฑ : Negative feedback์œผ๋กœ ์ธํ•ด TSH ๋‚ฎ์Œ. ํ•˜์ง€๋งŒ ๋‚ฎ๋‹ค๊ณ  ๋ฌด์กฐ๊ฑด ์ง„๋‹จ๋˜์ง„ ์•Š์Œ
โ€ข
์ด์ฐจ์„ฑ : Pituitary์˜ ๊ณผ์ƒ์„ฑ์œผ๋กœ ์ธํ•ด TSH ์ƒ์Šน

(2) free T4, free T3

โ€ข
๋‚ฎ์€ TSH + ๋†’์€ free T4๋กœ ์ผ์ฐจ์„ฑ ํ•ญ์ง„์ฆ์„ ํ™•์ง„.
โ€ข
๋†’์€ TSH + ๋†’์€ free T4 : ์ด์ฐจ์„ฑ ํ•ญ์ง„์ฆ

(3) Total T4, T3

โ€ข
๋Œ€๋ถ€๋ถ„์˜ ๊ฐ‘์ƒ์ƒ˜ ํ˜ธ๋ฅด๋ชฌ์€ protein bounding ์ƒํƒœ์ด๋ฏ€๋กœ ์ฃผ๋กœ bounding๋œ ํ˜ธ๋ฅด๋ชฌ ์ˆ˜์น˜ ์ธก์ •
โ€ข
Thyroid storm ์‹œ total T3, T4๋Š” ์ƒ์Šนํ•˜์ง€ ์•Š์„ ์ˆ˜๋„ ์žˆ์Œ
โ€ข
Protein bounding์— ์˜ํ–ฅ ์ฃผ๋Š” ์ปจ๋””์…˜์— ๋”ฐ๋ผ ๊ฒฐ๊ณผ ๊ฐ’์— ์˜ํ–ฅ๋ฐ›์Œ

(4) Thyroid Antibody Titers

โ€ข
Thyroid-stimulating Ab๊ฐ€ Graves'๋ณ‘์—์„œ ์ƒ์Šน. ์ด ์ˆ˜์น˜๊ฐ€ ์ง„๋‹จ์— ๋„์›€
โ€ข
TSI (TSH recetptor Ab)
โ€ข
Anti thyroglobulin Ab
โ€ข
Anti thyroperoxidase Ab

B3. Thyrodi Scan

โ€ข
Thyroid scan (Tc-99m)
โ€ข
Thyroid uptake (Tc-99m) ยท ์ •์ƒ์น˜ : 5โˆผ3O% ๏ผˆ๊ฐ‘์ƒ์„  ๊ธฐ๋Šฅ๊ณผ ๋น„๋ก€๏ผ‰ โ˜…

B4. ํ•ฉ๋ณ‘์ฆ ์—†๋Š” ๊ฐ‘์ƒ์„  ๊ธฐ๋Šฅ ํ•ญ์ง„์ฆ์˜ ์น˜๋ฃŒ

โ€ข
ํ•ฉ๋ณ‘์ฆ ์—†๋Š” ๊ฐ‘์ƒ์„  ๊ธฐ๋Šฅ ํ•ญ์ง„์ฆ ํ™˜์ž์˜ ์ถ”๊ฐ€ ํ‰๊ฐ€, ์น˜๋ฃŒ ๋ฐ ๊ฑฐ์ทจ๊ฒฐ์ •์€ ๋‚˜์ด, ๋™๋ฐ˜์งˆํ™˜, ์งˆ๋ณ‘ ์ค‘์ฆ๋„ ๋ฐ ๊ทผ๋ณธ ์›์ธ์— ๋”ฐ๋ผ ๋‹ค๋ฆ„. ๋Œ€๊ฐœ OPD ์ถ”์ ์ง„๋ฃŒ ๊ฐ€๋Šฅํ•จ.
โ€ข
๋‚ด๋ถ„๋น„ ์˜์‚ฌ ์™ธ๋ž˜ ์ง„๋ฃŒ โ†’ ๊ฐ‘์ƒ์„  sonogram, radioiodine scan
โ€ข
๋„ํ”Œ๋Ÿฌ ๊ฐ‘์ƒ์„  ์ดˆ์ŒํŒŒ ๊ฒ€์‚ฌ : ๊ฐ‘์ƒ์„  ํฌ๊ธฐ, ํ˜ˆ๊ด€์„ฑ ๋ฐ ๊ฒฐ์ ˆ ์กด์žฌ ํ‰๊ฐ€. ์ผ๋ฐ˜์ ์œผ๋กœ, ๊ณผ๋„ํ•œ ํ˜ธ๋ฅด๋ชฌ์„ ๋ถ„๋น„ํ•˜๋Š” ๊ฐ‘์ƒ์„ ์€ ์ปค์ง„๋‹ค. ๊ทธ๋Ÿฌ๋‚˜, ์•„๊ธ‰์„ฑ ์‚ฐํ›„ ๊ฐ‘์ƒ์„ ์—ผ, silent thyroiditis, ๋˜๋Š” exogenous cause ํ•ญ์ง„์ฆ์ธ ๊ฒฝ์šฐ ๊ฐ‘์ƒ์„  ๋น„๋Œ€๋Š” ์—†๋‹ค.
โ€ข
์š”์˜ค๋“œ-131์„ ์ด์šฉํ•œ ํ•ต์˜ํ•™ ์˜์ƒ์€ ์•ฝ์ œ ํˆฌ์—ฌ ํ›„ 1~2์‹œ๊ฐ„ ๋งŒ์— ๋ฐฉ์‚ฌ์„ฑ ์š”์˜ค๋“œ์˜ ํก์ˆ˜๊ฐ€ ํฌ๊ฒŒ ์ฆ๊ฐ€.

C. Thyroid storm

โ€ข
๊ฐ‘์ƒ์„ ํ•ญ์ง„์ฆ์ด ์žˆ๋˜ ํ™˜์ž์—์„œ ์ž„์ƒ์ ์œผ๋กœ ์ง„๋‹จํ•จ. ์ง„๋‹จ์ด๋‚˜ ์น˜๋ฃŒ ์œ„ํ•ด ๊ฒ€์‚ฌ ๊ฒฐ๊ณผ๋ฅผ ๊ธฐ๋‹ค๋ฆฌ์ง€ ๋ง ๊ฒƒ
โ€ข
Thyroid storm์ด ์žˆ๋Š”์ง€ ๊ฒฐ์ •ํ•˜๋Š” ๋ฐ์—๋Š” ์ดํ•˜์˜ main system์— ์ง‘์ค‘! : Thermoregulatory system (์ฒด์˜จ ์ƒ์Šน) : Cardiovascular system (Tachycardia to atrial fibrillation, CHF) : CNS (Agitation ~ Seizure) : GI-hepatic system (Nausea to vomiting, jaundice)

C1. Pathophysiology

โ€ข
Not clear ํ•˜์ง€๋งŒ thyroid hormone ๋ถ„๋น„ ์ฆ๊ฐ€ ๋˜๋Š” receptor sensitivity์˜ ์ฆ๊ฐ€์™€ ์—ฐ๊ด€
โ€ข
์ฆ์ƒ์˜ ๋Œ€๋ถ€๋ถ„์€ adrenergic hyperactivity์™€ ๊ด€๋ จ
โ€ข
Thyroid storm์—์„œ๋Š” uncomplicated hyperthyroidism๋ณด๋‹ค ์ƒ๋Œ€์ ์œผ๋กœ free thyroid hormone์ด ๋” ๋†’๋‹ค.
โ€ข
Thyroid storm ๋™์•ˆ, ๊ฐ์—ผ, ์ŠคํŠธ๋ ˆ์Šค, ๊ทผ๊ฒฝ์ƒ‰ ๋˜๋Š” ์™ธ์ƒ๊ณผ ๊ฐ™์€ precipitants๋Š” ๊ฐ‘์ƒ์„  ํ˜ธ๋ฅด๋ชฌ์„ ๊ฒฐํ•ฉ ๋ถ€์œ„์—์„œ ํ•ด๋ฐฉ์‹œํ‚ค๊ฑฐ๋‚˜ ์ˆ˜์šฉ์ฒด ๋ฏผ๊ฐ์„ฑ์„ ์ฆ๊ฐ€์‹œํ‚ด์œผ๋กœ์จ ๊ฐ‘์ƒ์„  ํ˜ธ๋ฅด๋ชฌ์˜ ํšจ๊ณผ๋ฅผ ์ฆ๊ฐ€์‹œํ‚จ๋‹ค.

C2. Precipitants of thyroid storm

โ€ข
Precipitant of thyroid storm (Table 229-4)
โ€ข
๊ฐ‘์ƒ์„  ๊ธฐ๋Šฅ ํ•ญ์ง„์ฆ์— ๋Œ€ํ•œ ๋ฐฉ์‚ฌ์„ฑ ์š”์˜ค๋“œ ์น˜๋ฃŒ๋ฅผ ๋ฐ›๋Š” ์ผ๋ถ€ ํ™˜์ž์˜ ๊ฒฝ์šฐ, ๊ฐ‘์ƒ์„  ํญํ’์€ ํ•ญ๊ฐ‘์ƒ์„  ์•ฝ๋ฌผ์˜ ์ถ”์ถœ, ์†์ƒ๋œ ๊ฐ‘์ƒ์„  ์—ฌํฌ์—์„œ ๊ฐ‘์ƒ์„  ํ˜ธ๋ฅด๋ชฌ์˜ ๋ฐฉ์ถœ ๋˜๋Š” ๋ฐฉ์‚ฌ์„ฑ ์š”์˜ค๋“œ ์ž์ฒด์˜ ์˜ํ–ฅ์œผ๋กœ ์ธํ•ด ์น˜๋ฃŒ ํ›„ ์•„์ด๋Ÿฌ๋‹ˆํ•˜๊ฒŒ๋„ ๋ฐœ์ƒํ•  ์ˆ˜ ์žˆ๋‹ค.

C3. Clinical features of thyroid storm

โ€ข
๊ธฐ์กด hyperthyroidism์˜ ์ฆ์ƒ ์™ธ ์ถ”๊ฐ€์ฆ์ƒ์ด ๋‚˜ํƒ€๋‚จ (Figure 229-1)
โ€ข
๋‘๊ทผ๊ฑฐ๋ฆผ, ๋นˆ๋งฅ, ํ˜ธํก๊ณค๋ž€์ด ํ”ํ•˜๋‹ค. pleuropericardial rub์ด ๋“ค๋ฆด ์ˆ˜ ์žˆ์Œ
โ€ข
๊ฐ‘์ƒ์„  ํ˜ธ๋ฅด๋ชฌ์ด ์‹ฌ์žฅ์— ๋ฏธ์น˜๋Š” ์ง์ ‘์ ์ธ inotropic / chronotropic effect : SV, contractility, CO ์ฆ๊ฐ€
โ€ข
์‹ฌ๊ทผ ์ˆ˜์ถ•๋ ฅ ์ฆ๊ฐ€๋กœ SBP ์ƒ์Šน
โ€ข
๋†’์€ CO๊ณผ ๋ง์ดˆ ํ˜ˆ๊ด€ ์ €ํ•ญ ๊ฐ์†Œ๋กœ ์ธํ•ด Pulse pressure widening.
โ€ข
A-fib์€ 10%์—์„œ 35%๋กœ ๋ฐœ์ƒ

(1) Burch and Wartofsky Point Scale (BWPS) Table 229-5

โ€ข
practicalํ•˜๊ณ  ๋ฏผ๊ฐ๋„๋Š” ๋†’์œผ๋‚˜, ํŠน์ด๋„๊ฐ€ ๋‚ฎ๋‹ค
โ€ข
Score of โ‰ฅ45: highly suggestive of thyroid storm. Score of 25โ€“44: suggestive of impending storm. Score of <25: unlikely to represent thyroid storm.

(2) ์ผ๋ณธ ๊ฐ‘์ƒ์„ ํ•™ํšŒ TS1, TS2 ์ง„๋‹จ๊ธฐ์ค€

โ€ข
BWPS๋ณด๋‹ค ๋ฏผ๊ฐ๋„๊ฐ€ ๋–จ์–ด์ง€๋Š” ๋“ฏ.

(3) Thyroid storm๊ณผ ๊ฐ๋ณ„ํ•ด์•ผ ํ•  ์ฃผ์š” ์งˆ๋ณ‘

C4. Laboratory testing, imaging and ecg

(1) Lab

โ€ข
UPT๋ฅผ ์ œ์™ธํ•˜๊ณ ๋Š” ๊ฒ€์‚ฌ๊ฒฐ๊ณผ ๊ธฐ๋Œ€๋ผ์ง€ ๋ง๊ณ  ์˜์‹ฌ๋˜๋ฉด ๋ฐ”๋กœ ์น˜๋ฃŒ ์‹œ์ž‘
โ€ข
CBC : typical ํ•˜๊ฒŒ Leukocytosis with shift to left ๋ณด์ž„
โ€ข
Hyperglycemia ๊ฒฝํ–ฅ ๋ณด์ž„ : catecholamine ์œผ๋กœ ์ธํ•œ ์ธ์А๋ฆฐ ๋ถ„๋น„์–ต์ œ, ๊ธ€๋ฆฌ์ฝ”๊ฒ๋ถ„ํ•ด์ฆ๊ฐ€, ์žฅ์—์„œ์˜ ํฌ๋„๋‹น ํก์ˆ˜ ๋นจ๋ผ์ง์œผ๋กœ ์ธํ•ด
โ€ข
Mild hypercalcemia, ALP ์ฆ๊ฐ€ : bone reabsorption ์ฆ๊ฐ€๋กœ ์ธํ•ด
โ€ข
Live enzyme ์ฆ๊ฐ€ (PTU ํˆฌ์—ฌ ์‹œ์—๋„ ์•ฝ๊ฐ„ ์ƒ์Šน ๊ฐ€๋Šฅ)
โ€ข
Cortisol ์ฆ๊ฐ€. (Cortisol ๋‚ฎ๋‹ค๋ฉด AI ๋™๋ฐ˜์˜์‹ฌ)

(2) image

โ€ข
๋‹ค๋ฅธ ์งˆ๋ณ‘ ๊ฐ๋ณ„ ์œ„ํ•ด ํ•„์ˆ˜
โ€ข
์‹ฌ์ดˆ์ŒํŒŒ : typically show tachycardia, enhanced LV contractility, and a dilated IVC in the presence of high-output cardiac failure.

(3) EKG

โ€ข
40% ์ •๋„์—์„œ S.Tachycardia
โ€ข
A-Fib ์€ 10~35% ์ •๋„์—์„œ ๋ฐœ์ƒ. ๊ตฌ์กฐ์  ์‹ฌ์žฅ์ด์ƒ ๋ฐ 60์„ธ ์ด์ƒ ์‹œ ๋” ์ž์ฃผ ๋ฐœ์ƒ
โ€ข
VPC, AV block, APC, A-flutter ๋ณด์ผ ์ˆ˜ ์žˆ์Œ.

D. ๊ฐ‘์ƒ์„ ํญํ’์˜ ์น˜๋ฃŒโ˜…

โ€ข
์น˜๋ฃŒ์˜ ์ˆœ์„œ๋Š” ๊ต‰์žฅํžˆ ์ค‘์š”ํ•จ. ์น˜๋ฃŒ ์ „ ๊ฐ€์ž„๊ธฐ ์—ฌ์„ฑ์€ ๋ฐ˜๋“œ์‹œ ์ž„์‹  ๊ฒ€์‚ฌ ํ™•์ธ ํ•„์š”ํ•จ. * ์ž„๋ถ€์ด๊ฑฐ๋‚˜ ๋ชจ์œ ์ˆ˜์œ  ์ค‘์ธ ์‚ฐ๋ชจ๋Š” ํ˜‘์ง„

(1) ์น˜๋ฃŒ ๋ชฉํ‘œ

โ€ข
Supportive care
โ€ข
Inhibition of peripheral adrenergic effects
โ€ข
Inhibition of new hormone synthesis
โ€ข
Inhibition of thyroid hormone release
โ€ข
Preventing peripheral conversion of T4 to T3
โ€ข
Preventing free thyroid hormone reabsorption
โ€ข
Treating the precipitant
โ€ข
Definitive care

D1. ์ง€์ง€์  ์น˜๋ฃŒ

(1) ์ผ๋ฐ˜

โ€ข
์‚ฐ์†Œํˆฌ์—ฌ, ์‹ฌ์ „๋„ ๊ฐ์‹œ ๋ถ€์ฐฉ

(2) Fever control

โ€ข
์•„์ด์ŠคํŒฉ, ์ฟจ๋ง๋‹ด์š”, AAP (325~640 mg q 4~6hr)
โ€ข
์•„์Šคํ”ผ๋ฆฐ ์ด๋‚˜ ๋‹ค๋ฅธ NSAIDs๋Š” T4๋ฅผ ๊ฒฐํ•ฉ๋‹จ๋ฐฑ์—์„œ ์œ ๋ฆฌ์‹œ์ผœ ์ฆ์ƒ์„ ์•…ํ™”์‹œํ‚ฌ ์ˆ˜ ์žˆ์–ด ๊ธˆ๊ธฐ.
โ€ข
Cooling blanket, fans, ice packs, ice lavage ๋ณ‘ํ–‰

(3) ํƒˆ์ˆ˜์— ๋Œ€ํ•œ ์ˆ˜์•ก๋ณด์ถฉ

โ€ข
glucose level ๋‚ฎ์œผ๋ฉด Glycogen ๋ถ€์กฑ์„ ๋ณด์ถฉํ•˜๊ธฐ ์œ„ํ•ด 5DS ๋‚˜ 10% DW ์ˆ˜์•ก ์‚ฌ์šฉ

(4) Nutrition

โ€ข
Glucose, Multivitamin, Thiamine, Including folate
(6) ์•…ํ™”์ธ์ž ์ œ๊ฑฐ, ์›์ธ์ธ์ž ์ฐพ๊ธฐ
โ€ข
๊ฐ์—ผ์ด ๊ฐ€์žฅ ํ”ํ•œ ์œ ๋ฐœ์ธ์ž์ด๋ฏ€๋กœ ์ด์— ๋Œ€ํ•˜์—ฌ ์ฃผ์˜๊นŠ๊ฒŒ ์‚ดํŽด๋ณด์•„์•ผ ํ•œ๋‹ค.
(7) Shivering ์กฐ์ ˆ : meperidine ๊ณผ Chlorpromazine IV
(8) Parenteral vitamin supplements (์˜ˆ: vitamin B-complex)
(9) Miscellaneous
โ€ข
Lorazepam or diazepam as anxiolytic and to decrease central sympathetic outflow
โ€ข
Cholestyramine (blocks enterohepatic recirculation of thyroid hormone), 1โ€“4 g PO twice daily for severe or refractory thyrotoxicosis
โ€ข
์ˆ˜์•ก์˜ ๊ณต๊ธ‰๋งŒ์œผ๋กœ ํšŒ๋ณต๋˜์ง€ ์•Š๋Š” ์‡ผํฌ๋Š” ์Šน์••์ œ๋ฅผ ์‚ฌ์šฉํ•˜๋‚˜ ์ด ๊ฒฝ์šฐ ์˜ˆํ›„๋Š” ๊ทนํžˆ ๋‚˜์จ

D2. ๋ง์ดˆ ์•„๋“œ๋ ˆ๋‚ ๋ฆฐ ํšจ๊ณผ ์–ต์ œ

: high-ouput HF ์œ„ํ—˜์ด ์žˆ๋Š” hyperadrenegic ์ƒํƒœ์ด๋ฏ€๋กœ, afterload์™€ HR ์ค„์ด๊ธฐ ์œ„ํ•ด beta blocker ํˆฌ์—ฌ๊ฐ€ ํ•„์š”ํ•จ.

(1) Propranolol

: non-selective ๋ฒ ํƒ€ ์ฐจ๋‹จ์ œ๋กœ, ๋ง์ดˆ์—์„œ T4โ†’T3 ์ „ํ™˜์„ ์ฐจ๋‹จํ•˜๋ฏ€๋กœ esmolol๋ณด๋‹ค ์œ ๋ฆฌํ•˜๋‹ค. ๊ทธ๋Ÿฌ๋‚˜ ์ตœ๊ทผ ์—ฐ๊ตฌ์— ๋”ฐ๋ฅด๋ฉด, ์‹ฌํ•œ storm ์‹œ์—๋Š” ์ด๋ฏธ ์ „ํ™˜์ด ๊ฐ์†Œํ•œ ์ƒํƒœ๋ผ๊ณ  ํ•œ๋‹ค.
โ€ข
IV ํˆฌ์—ฌ : 1~2 mg IV bolus ํ›„ 10~15๋ถ„ ๋งˆ๋‹ค ๋ฐ˜๋ณต โ†’ V/S ๊ด€์ฐฐํ•˜๋ฉฐ ๋ชฉํ‘œ ๋‹ฌ์„ฑ์‹œ๊นŒ์ง€ (์ฆ์ƒํ˜ธ์ „, ๋งฅ๋ฐ•์ €ํ•˜) : 0.5~1 mg IV over 10 min ํ›„ ์ˆ˜ ์‹œ๊ฐ„ ๊ฐ„๊ฒฉ์œผ๋กœ ์šฉ๋Ÿ‰์กฐ์ ˆํ•˜์—ฌ 1~2 mg ๊นŒ์ง€ ์ฆ๋Ÿ‰
โ€ข
PO ํˆฌ์—ฌ (Tepra tab 40mg) - Toxicity ๊ฐ€ ๋‚ฎ์€ ๊ฒฝ์šฐ : ๋ณดํ†ต 20~120 mg ์œผ๋กœ ํˆฌ์—ฌ ์‹œ์ž‘, 160~320 mg/day ๋ฅผ ๋‚˜๋ˆ„์–ด ํˆฌ์—ฌ : 60~120 mg ์”ฉ 6์‹œ๊ฐ„ ๊ฐ„๊ฒฉ์œผ๋กœ ๊ฒฝ์šฐํˆฌ์—ฌ ํ•˜๊ฑฐ๋‚˜ : 60~80 mg ์”ฉ 4์‹œ๊ฐ„๋งˆ๋‹ค ํˆฌ์—ฌ

(2) Esmolol

โ€ข
Loading dose : 250~500mcg/kg IV, then Continuous : 50~100 mcg/kg/min
โ€ข
short acting ฮฒ-blocker๊ฐ€ ์ ์ ˆํ•˜๋‹ค
โ€ข
๊ฒฝ๊ตฌ bisoprolol ๋„ ์‚ฌ์šฉ๊ฐ€๋Šฅํ•จ.

(3) Reserpine

โ€ข
1 mg ์‹œํ—˜ ํˆฌ์—ฌ ํ›„ 2.5-5.0 mg IM every 4~6 hr
โ€ข
๊ต๊ฐ ์‹ ๊ฒฝ ๋ง๋‹จ๊ณผ CNS์˜ ์นดํ…Œ์ฝœ๋ผ๋ฏผ ์ €์žฅ์†Œ๋ฅผ ๊ณ ๊ฐˆ์‹œํ‚ค๋Š” ์•Œ์นผ๋กœ์ด๋“œ ๋ฌผ์งˆ โ†’ CNS ์–ต์ œ ํšจ๊ณผ ๋‚˜ํƒ€๋‚  ์ˆ˜ ์žˆ์Œ
โ€ข
ฮฒ-blocker๊ฐ€ contraindication์ผ ๋•Œ

(5) Guanethidine

โ€ข
์นดํ…Œ์ฝœ๋ผ๋ฏผ ๋ฐฉ์ถœ ์–ต์ œ์ œ
โ€ข
30~40mg PO every 6hr
โ€ข
ฮฒ-blocker๊ฐ€ contraindication์ผ ์‹œ
โ€ข
ํ˜ˆ์••์ €ํ•˜ ๋ถ€์ž‘์šฉ ์žˆ์–ด CHF ๋‚˜ ์ €ํ˜ˆ์••, Cardiogenic shock ์‹œ ์‚ฌ์šฉ๊ธˆ๊ธฐ

D3. ์ƒˆ๋กœ์šด ๊ฐ‘์ƒ์ƒ˜ ํ˜ธ๋ฅด๋ชฌ ํ•ฉ์„ฑ ์–ต์ œ

โ€ข
ํ•ญ๊ฐ‘์ƒ์„ ์ œ๋Š” ๊ฒฝ๊ตฌ๋กœ๋งŒ ํˆฌ์—ฌํ•  ์ˆ˜ ์žˆ์œผ๋ฏ€๋กœ ์˜์‹์ด ๋‚˜์œ ๊ฒฝ์šฐ๋Š” ์œ„์— ์‚ฝ๊ด€ํ•˜์—ฌ ํˆฌ์—ฌํ•œ๋‹ค.
โ€ข
Thioamide (methimazol, PTU)๋Š” Iodine์— ๋Œ€ํ•œ iodide์˜ organification๊ณผ trapping์„ ๋ฐฉ์ง€ํ•˜๊ณ  iodotyrosine์˜ coupling์„ ์–ต์ œํ•จ์œผ๋กœ์จ ๊ฐ‘์ƒ์„  ํ˜ธ๋ฅด๋ชฌ์˜ ํ•ฉ์„ฑ์„ ์–ต์ œํ•œ๋‹ค.

(1) Methimazole

โ€ข
์›๋‚ด์•ฝ์ œ : Methimazole 5mg/Tab
โ€ข
20mg q 6hr PO, max 60~80mg
โ€ข
FDA category D. ์ž„์‹  1๋ถ„๊ธฐ ๋•Œ ํŠนํžˆ teratogenic
โ€ข
PO, NG, PR ๋ชจ๋‘ ๊ฐ™์€ ์šฉ๋Ÿ‰์œผ๋กœ ํˆฌ์—ฌ ๊ฐ€๋Šฅ
โ€ข
์„ฑ์ธ: ๊ฒฝ์ฆ 15mg/day, ์ค‘๋“ฑ๋„ 30-40mg/day, ์ค‘์ฆ 60mg/day, 1์ผ 3ํšŒ ๋ถ„๋ณต. ์œ ์ง€๋Ÿ‰์€ 5-15mg/day, 1-2ํšŒ ๋ถ„๋ณต. ์†Œ์•„: 0.4mg/kg/day, 1์ผ 3ํšŒ ๋ถ„๋ณต. ์œ ์ง€๋Ÿ‰์œผ๋กœ ์ดˆ๊ธฐ๋Ÿ‰์˜ ๋ฐ˜๋Ÿ‰.
โ€ข
MMI๋ฅผ ํˆฌ์—ฌํ•˜๋Š” ๊ฒฝ์šฐ๋Š” 100 mg์˜ ๋ถ€ํ•˜์šฉ๋Ÿ‰์„ ํˆฌ์—ฌํ•œ ํ›„ 20 mg ์„ ๋งค 4์‹œ๊ฐ„๋งˆ๋‹ค ํˆฌ์—ฌํ•œ๋‹ค.
โ€ข
ํ˜ธ๋ฅด๋ชฌ ์ •์ƒํ™”์— ์ˆ˜ ์ผ ์ •๋„ ์†Œ์š”๋จ

(2) PTU

: ๊ฐ‘์ƒ์„  ๋ฐ–์—์„œ๋Š” PTU๋งŒ์ด T4โ†’T3 ์ „ํ™˜ ์–ต์ œ๊ฐ€ ๊ฐ€๋Šฅํ•จ
โ€ข
์›๋‚ด์•ฝ์ œ : Antiroid 50mg/Tab
โ€ข
Loading dose : 500~1000mg PO
โ€ข
F/U dose: 250mg every 4hr
โ€ข
๋ง์ดˆ์—์„œ T4 โ†’ T3 ์ „ํ™˜ ๋ง‰๋Š” ํšจ๊ณผ (์ด๋ฏธ ๋งŒ๋“ค์–ด์ง„ T4 ์˜ ๋ถ„๋น„์—๋Š” ์˜ํ–ฅ์ด ์—†๋‹ค)
โ€ข
๊ฐ„๋…์„ฑ ๋•Œ๋ฌธ์— FDA์—์„œ Methimazole์„ ์šฐ์„ ๊ถŒ์žฅ.
โ—ฆ
๋‹ค๋ฅธ ๋ฌธํ—Œ์—์„œ๋Š” ์ดˆ๊ธฐ์—๋Š” ๋…์„ฑ ์ž˜ ์•ˆ ๋‚˜ํƒ€๋‚˜์„œ PTU ๊ถŒ์žฅํ•˜๊ธฐ๋„
โ—ฆ
์ž„์‹  1๊ธฐ์—์„œ๋งŒ teratogenicity ๋•Œ๋ฌธ์— PTU๋ฅผ 1st choice๋กœ ๊ถŒ๊ณ ํ•˜๊ณ  2~3๊ธฐ์—๋Š” MTZ
โ—ฆ
LFT์ด ์ •์ƒ 3๋ฐฐ ์ด์ƒ ๋„๋‹ฌ ์‹œ, PTU ์‚ฌ์šฉ ํ›„ LFT ์ƒ์Šน ๋ณด์ผ ์‹œ PTU ์ค‘๋‹จ
โ€ข
PO, NG, PR ๋ชจ๋‘ ๊ฐ™์€ ์šฉ๋Ÿ‰์œผ๋กœ ํˆฌ์—ฌ ๊ฐ€๋Šฅ
โ—ฆ
์„ฑ์ธ: ์ดˆ๊ธฐ๋Ÿ‰ 1์ผ 100-300mg/day์„ 3-4ํšŒ ๋ถ„๋ณต, ์ค‘์ฆ์—๋Š” 1์ผ 400-600mg๊นŒ์ง€ ํˆฌ์—ฌ. ๊ฐ‘์ƒ์„ ๊ธฐ๋Šฅํ•ญ์ง„์ฆ ์†Œ์‹ค์‹œ 1-4์ฃผ๊ฐ„ ์ ์ง„์ ์œผ๋กœ ๊ฐ๋Ÿ‰ํ•˜์—ฌ ์œ ์ง€๋Ÿ‰ 25-100mg/day์„ 1-2ํšŒ ๋ถ„๋ณต.
โ—ฆ
์†Œ์•„: ์ดˆ๊ธฐ๋Ÿ‰: 5-9์„ธ 100-200mg/day, 10-14์„ธ 200-300mg/day์„ 2-4ํšŒ ๋ถ„๋ณต. ๊ฐ‘์ƒ์„ ๊ธฐ๋Šฅํ•ญ์ง„์ฆ ์†Œ์‹ค์‹œ 1-4์ฃผ๊ฐ„ ์ ์ง„์ ์œผ๋กœ ๊ฐ๋Ÿ‰ํ•˜์—ฌ ์œ ์ง€๋Ÿ‰ 50-100mg/day์„ 1-2ํšŒ ๋ถ„๋ณต. ๊ธฐํƒ€ ์ž์„ธํ•œ ์‚ฌํ•ญ์€ ์ œํ’ˆ์„ค๋ช…์„œ ์ฐธ์กฐ.
โ€ข
900 ~ 1200 mg PO (์ฒซ ๋‚ ) โ†’ 300 mg/day 3~6์ฃผ ๊ฐ„
โ€ข
100 mg์˜ PTU Lpoading ํ›„ ๋งค์ผ 600๏ฝž1200 mg์˜ PTU๋ฅผ 100๏ฝž200 mg ๋กœ ๋ถ„ํ•  q 4 hr

D4. ๊ฐ‘์ƒ์ƒ˜ํ˜ธ๋ฅด๋ชฌ ๋ฐฉ์ถœ์–ต์ œ

โ€ข
Iodine Lugol solution, Potassium iodide, ipodate (Oragrafin), Lithium carbonate
โ€ข
ํ•ญ๊ฐ‘์ƒ์„ ์ œ์˜ ํˆฌ์—ฌ๋ฅผ ์‹œ์ž‘ํ•˜๊ณ  1๏ฝž2์‹œ๊ฐ„ ํ›„ ํˆฌ์—ฌ (๋จผ์ € ํˆฌ์—ฌํ•˜๋ฉด ์ค‘๋…์ฆ ์•…ํ™”)
โ—ฆ
PTU๋‚˜ Methimazole์€ Thyroid Gland์—์„œ Thyroid hormone์˜ synthesis๋ฅผ ์–ต์ œํ•จ. Thyroid hormone์˜ ์ƒํ•ฉ์„ฑ์ด ์–ต์ œ๋œ๋‹ค ํ•˜๋”๋ผ๋„, Thyroid Gland ์•ˆ์— ์ €์žฅ๋˜์–ด ์žˆ๋˜ Thyroid hormone์ด ๋ถ„๋น„๋  ์ˆ˜ ์žˆ๋Š”๋ฐ Iodine์€ ์ด๋ฅผ ์–ต์ œํ•ด ์ฃผ๋Š” ์—ญํ• ์„ ํ•จ. Iodinea์„ Thyroid gland๊ฐ€ ํ™œ์„ฑํ™”๋˜์–ด ์žˆ์„ ๋•Œ ์ฃผ๋ฉด ์ „๋ฐ˜์ ์ธ Thyroid hormone์˜ ๋ถ„๋น„๊ฐ€ ์–ต์ œ๋˜๊ณ , ์ด๋Š” negative feedback ์ž‘์šฉ์œผ๋กœ Thyroid ์ƒํ•ฉ์„ฑ์„ ์ฆ๊ฐ€์‹œํ‚ฌ ์ˆ˜ ์žˆ๋‹ค.

(1) Iodine solution

โ€ข
ํˆฌ์—ฌ๊ธˆ๊ธฐ : Iodine ์— ๊ณผ๋ฏผ์ฆ, iodine overload, iodine ์œ ๋ฐœ์„ฑ / amiodarone ์œ ๋ฐœ์„ฑ ๊ฐ‘์ƒ์ƒ˜ ํ•ญ์ง„์ฆ
โ€ข
Lugol solution
โ—ฆ
์ด๋ฏธ ์ƒ์„ฑ๋˜์–ด ๊ฐ‘์ƒ์„ ์— ์ €์žฅ๋œ ํ˜ธ๋ฅด๋ชฌ ๋ถ„๋น„์˜ ์–ต์ œํšจ๊ณผ
โ—ฆ
Lugol solution (8 mg/drop) : 8~10 ๋ฐฉ์šธ 6 ์‹œ๊ฐ„๋งˆ๋‹ค ๊ฒฝ๊ตฌ ํˆฌ์—ฌ
โ€ข
Oragrafin (ipodate ํ•จ์œ ํ•œ Iodinated radiocontrast dye)
โ—ฆ
0.5~3g/day PO
โ€ข
Telepaque (IV iopanoic acid)
โ—ฆ
์ฒซ 24์‹œ๊ฐ„๋™์•ˆ 1g ์„ 8์‹œ๊ฐ„๋งˆ๋‹ค IV โ†’ 500 mg bid
โ€ข
Saturated solution of potassium iodide
โ—ฆ
SSKI (50 mg iodide/drop), 1โ€“2 drops PO or PR tid
โ—ฆ
์›๋‚ด์•ฝ์ œ : Gemstein solution 10ml/V 0.2 mL๋ฅผ ๋ฌผ์ด๋‚˜ ์šฐ์œ ์— ํฌ์„ํ•˜์—ฌ 1์ผ 3ํšŒ 6์ผ๊ฐ„ ๋ณต์šฉ

(2) Iodine ํˆฌ์—ฌ๊ธˆ๊ธฐ์ธ ๊ฒฝ์šฐ ๋Œ€์ฒด์•ฝ์ œ

โ€ข
Potassium Perchlorate - iodine์˜ thyroid uptake ์ฐจ๋‹จ
โ—ฆ
0.5g / day
โ—ฆ
์ฃผ๋กœ amiodarone ์œ ๋ฐœ์„ฑ ํ•ญ์ง„์ฆ์— ์‚ฌ์šฉ
โ—ฆ
๋ถ€์ž‘์šฉ : aplastic anemia, nephrotic syndrome
โ€ข
Lithium carbonate
โ—ฆ
์‹ฌํ•œ storm์ผ ๋•Œ, PTU๋‚˜ methimazole๊ณผ ๊ฐ™์ด ์‚ฌ์šฉ๊ฐ€๋Šฅ
โ—ฆ
๊ฐ‘์ƒ์ƒ˜์—์„œ ํ˜ธ๋ฅด๋ชฌ ๋ฐฉ์ถœ ์–ต์ œ, ์ƒํ•ฉ์„ฑ ์–ต์ œ
โ—ฆ
300 mg PO 8์‹œ๊ฐ„๋งˆ๋‹ค
โ—ฆ
๋ฆฌํŠฌ ์ค‘๋… ํ”ผํ•˜๊ธฐ ์œ„ํ•ด ๋งค์ผ ๋ฆฌํŠฌ๋†๋„ ์ธก์ • - 0.6~1.0 mEq/L ํ˜ˆ์ค‘๋†๋„ ์œ ์ง€
โ—ฆ
์ตœ๊ธฐํ˜• ํšจ๊ณผ ์žˆ์–ด ์ž„์‹  ์‹œ ํˆฌ์—ฌ๋ถˆ๊ฐ€

D5. ๋ง์ดˆ์—์„œ T4 โ†’ T3 ์ „ํ™˜ ์ฐจ๋‹จ

โ€ข
PTU, propranolol, glucocorticoid์— ์˜ํ•ด ์ฐจ๋‹จ๋จ (PTU, propranolol์˜ ํšจ๊ณผ๋Š” ๋ฏธ๋ฏธํ•จ) โ†’ Hydrocortisone ๋˜๋Š” Dexa4methasone๊ณผ ๊ฐ™์€ Glucocorticoid๊ฐ€ ์น˜๋ฃŒ์— ํ•„์ˆ˜์  โ†’ glucocorticoid ๋Š” ์ €ํ˜ˆ์•• ์žˆ๋Š” ์‹ฌํ•œ storm์—์„œ AI๊ฐ€ ๋™๋ฐ˜๋˜์–ด ์žˆ์„ ์ˆ˜ ์žˆ์–ด, ํ•„์ˆ˜์ ์œผ๋กœ ํˆฌ์—ฌํ•œ๋‹ค.

(1) Hydrocortisone (Cortisolu 100mg/V)

โ€ข
hydrocortisone 300mg IV ํ›„ 8์‹œ๊ฐ„ ๊ฐ„๊ฒฉ์œผ๋กœ 100 mg IV ์„ stable ํ•ด์งˆ ๋•Œ ๊นŒ์ง€ ํˆฌ์—ฌ
โ€ข
Hydrocortisone sodium succinate โ€“ Cortisolu 100mg/V ๋˜๋Š” 250~500 mg

(2) Dexamethasone (Dexamethasone 5mg/A)

โ€ข
2-4 mg IV every 6hr
โ€ข
Dexamethasone disodium phosphate โ€“ Dexamethasone disodium 5mg/A

D6. ๊ฐ‘์ƒ์ƒ˜ํ˜ธ๋ฅด๋ชฌ ์žฌํก์ˆ˜์–ต์ œ / ์ œ๊ฑฐ

โ€ข
๊ฐ‘์ƒ์„  ํ˜ธ๋ฅด๋ชฌ์€ ์ฃผ๋กœ ๊ฐ„์—์„œ ๋Œ€์‚ฌ๋˜๋ฉฐ, ๊ทธ๊ณณ์—์„œ ๊ธ€๋ฃจ์ฟ ๋กœ๋‹ˆ๋“œ์™€ ํ™ฉ์‚ฐ์—ผ๊ณผ ๊ฒฐํ•ฉ๋œ๋‹ค. ์ด ์ ‘ํ•ฉ ์‚ฐ๋ฌผ์€ ๋‹ด์ฆ™์—์„œ ๋ฐฐ์„ค๋œ๋‹ค. ์ž์œ  ํ˜ธ๋ฅด๋ชฌ์€ ์žฅ์—์„œ ๋ฐฉ์ถœ๋˜๊ณ  ์žฌํก์ˆ˜๋œ๋‹ค (enterohepatic circulation) ๊ฐ‘์ƒ์„ ๋…์ฆ ์ƒํƒœ์—์„œ๋Š” ๊ฐ‘์ƒ์„  ํ˜ธ๋ฅด๋ชฌ์˜ enterohepatic circulation์ด ์ฆ๊ฐ€ํ•œ๋‹ค. ์ฝœ๋ ˆ์Šคํ‹ฐ๋ผ๋ฏผ์€ ์žฅ์—์„œ ๊ฐ‘์ƒ์„  ํ˜ธ๋ฅด๋ชฌ์˜ ์žฌํก์ˆ˜๋ฅผ ๊ฐ์†Œ์‹œํ‚ค๋Š” ์Œ์ด์˜จ ๊ตํ™˜ ์ˆ˜์ง€์ด๋‹ค.
โ€ข
Methimazol ๋˜๋Š” PTU์™€ ๊ฒฐํ•ฉ๋œ ์ฝœ๋ ˆ์Šคํ‹ฐ๋ผ๋ฏผ์€ Thioamide ๋‹จ๋… ์น˜๋ฃŒ๋ณด๋‹ค ๊ฐ‘์ƒ์„  ํ˜ธ๋ฅด๋ชฌ ์ˆ˜์น˜๊ฐ€ ๋” ๋น ๋ฅด๊ฒŒ ๊ฐ์†Œ.
โ€ข
Cholestyramine 4g q 6hr
โ€ข
Plasmaperesis, Charcoal hemoperfusion, resin hemoperfusion, plasma exchange : ์ „ํ†ต์ ์ธ ์น˜๋ฃŒ ์กฐ์น˜์— ์ž˜ ๋ฐ˜์‘ํ•˜์ง€ ์•Š๋Š” ๊ฐ‘์ƒ์„  ํญํ’ ํ™˜์ž์˜ ๊ฐ‘์ƒ์„  ํ˜ธ๋ฅด๋ชฌ ์ˆ˜์น˜๋ฅผ ๋น ๋ฅด๊ฒŒ ์ค„์ด๋Š” ๋ฐ ํšจ๊ณผ์ ์œผ๋กœ ์‚ฌ์šฉ๋  ์ˆ˜ ์žˆ๋‹ค.

D7. Treat precipitating event

โ€ข
Thyroid Storm์„ ์œ ๋ฐœ์‹œํ‚ค๋Š” ์›์ธ์— ๋Œ€ํ•œ ๊ต์ •์ด ํ•„์š”ํ•จ : Infection, MI, DKA, pulmonary embolism ๋“ฑ์— ๋Œ€ํ•œ ๊ต์ •์ด ํ•„์š”

D8. Definitive Treatment

: Radioactive Iodine ablation therapy or Surgery